- Home
- CNTX vs MCN Comparison
CNTX vs MCN Comparison
Compare CNTX & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTX | MCN |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.7M | 125.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTX | MCN |
|---|---|---|
| Price | $1.56 | $6.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $5.67 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 52.9K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $6.69 |
| 52 Week High | $2.00 | $8.60 |
Technical Indicators
Market Signals| Indicator | CNTX | MCN |
|---|---|---|
| Relative Strength Index (RSI) | 66.41 | 62.51 |
| Support Level | $1.09 | $6.04 |
| Resistance Level | $1.79 | $6.12 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 51.89 | 84.00 |
Price Performance
Historical ComparisonAbout CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.